Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial Pullarkat, V. A., Levis, M., Mannis, G. N., Strickland, S. A., Lin, T. L., Faderl, S., Chakravarthy, D., Chandrasekaran, V., Cheung, R. S., Erba, H. P. AMER SOC HEMATOLOGY. 2021

View details for DOI 10.1182/blood-2021-148054

View details for Web of Science ID 000736398804292